Rodolphe Guinamard

Rodolphe Guinamard

Auto-generated profile, based on publicly available information

Rodolphe Guinamard

Université Côte D'Azur, Laboratoire de PhysioMédecine Moléculaire, CNRS, Nice, France

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2000 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
RGRodolphe Guinamard
Rodolphe Guinamard
MOMitsuhiko Okigaki
Mitsuhiko Okigaki
JSJoseph Schlessinger
Joseph Schlessinger
JRJeffrey V. Ravetch
Jeffrey V. Ravetch

9 August 1996 in Science
Verified
Journal Article
Closed access
PDF file
MLMichael Leitges
Michael Leitges
CSChristian Schmedt
Christian Schmedt
RGRodolphe Guinamard
Rodolphe Guinamard
JDJean Davoust
Jean Davoust
SSStefan Schaal
Stefan Schaal
ATAlexander Tarakhovsky
Alexander Tarakhovsky
Cross-linking of the antigen receptor on lymphocytes by antigens or antibodies to the receptor results in activation of enzymes of the protein kinase C (PKC) family. Mice homozygous for a targeted disruption of the gene encoding the PKC-βI and PKC-βII isoforms develop an immunodeficiency characterized by impaired humoral immune responses and reduced cellular responses of B cells, which is similar to X-linked immunodeficiency in mice. Thus PKC-βI and PKC-βII play an important role in B cell activation and may be functionally linked to Bruton's tyrosine kinase in antigen receptor-mediated signal transduction.

4 January 1999 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
RCRaphael Clynes
Raphael Clynes
JMJay S. Maizes
Jay S. Maizes
RGRodolphe Guinamard
Rodolphe Guinamard
MOMasao Ono
Masao Ono
TTToshiyuki Takai
Toshiyuki Takai
JRJeffrey V. Ravetch
Jeffrey V. Ravetch
Autoantibodies and immune complexes are major pathogenic factors in autoimmune injury, responsible for initiation of the inflammatory cascade and its resulting tissue damage. This activation results from the interaction of immunoglobulin (Ig)G Fc receptors containing an activation motif (ITAM) with immune complexes (ICs) and cytotoxic autoantibodies which initiates and propagates an inflammatory response. In vitro, this pathway can be interrupted by coligation to FcγRIIB, an IgG Fc receptor containing an inhibitory motif (ITIM). In this report, we describe the in vivo consequences of FcγRII deficiency in the inflammatory response using a mouse model of IC alveolitis. At subthreshold concentrations of ICs that fail to elicit inflammatory responses in wild-type mice, FcγRII-deficient mice developed robust inflammatory responses characterized by increased hemorrhage, edema, and neutrophil infiltration. Bronchoalveolar fluids from FcγRII−/− stimulated mice contain higher levels of tumor necrosis factor and chemotactic activity, suggesting that FcγRII deficiency lowers the threshold of IC stimulation of resident cells such as the alveolar macrophage. In contrast, complement- and complement receptor–deficient mice develop normal inflammatory responses to suprathreshold levels of ICs, while FcRγ−/− mice are completely protected from inflammatory injury. An inhibitory role for FcγRII on macrophages is demonstrated by analysis of FcγRII−/− macrophages which show greater phagocytic and calcium flux responses upon FcγRIII engagement. These data reveal contrasting roles for the cellular receptors for IgG on inflammatory cells, providing a regulatory mechanism for setting thresholds for IC sensitivity based on the ratio of ITIM to ITAM FcγR expression. Exploiting the FcγRII inhibitory pathway could thus provide a new therapeutic approach for modulating antibody-triggered inflammation.

21 July 2003 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MKMikael C.I. Karlsson
Mikael C.I. Karlsson
RGRodolphe Guinamard
Rodolphe Guinamard
SBSilvia Bolland
Silvia Bolland
MSMarko Sankala
Marko Sankala
RSRalph M. Steinman
Ralph M. Steinman
JRJeffrey V. Ravetch
Jeffrey V. Ravetch
The marginal zone of the spleen is a precisely ordered region that contains specialized subsets of B lymphocytes and macrophages. Disruption of the negative signaling inositol phosphatase, SH2-containing inositol-5-phosphatase 1 (SHIP), results in the loss of marginal zone B cells (MZBs) with reorganization of marginal zone macrophages (MZMOs) to the red pulp of the spleen. This primary macrophage defect, as revealed by selectively depleting SHIP in myeloid cells shows that MZMOs are specifically required for the retention of MZBs. The MZMO phenotype was reverted in SHIP/Bruton's tyrosine kinase (Btk) double knockout mice, thus identifying the Btk activating pathway as an essential component being regulated by SHIP. Furthermore, we identified a direct interaction between the MARCO scavenger receptor on MZMOs and MZBs. Activation or disruption of this interaction results in MZB migration to the follicle. The migration of the MZMOs was further studied after the response to Staphylococcus aureus, which induced MZMOs to move into the red pulp while MZBs migrated into the follicular zone. The marginal zone is therefore a dynamic structure in which retention and trafficking of B cells requires specific macrophage–B cell interactions.

1 June 1999 in Immunity
Verified
Journal Article
Closed access
RPRoger N Pearse
Roger N Pearse
TKTsutomu Kawabe
Tsutomu Kawabe
SBSilvia Bolland
Silvia Bolland
RGRodolphe Guinamard
Rodolphe Guinamard
TKTomohiro Kurosaki
Tomohiro Kurosaki
JRJeffrey V Ravetch
Jeffrey V Ravetch

11 May 2018 in Circulation Research
Verified
Journal Article
Closed access
PDF file
MVManon Viaud
Manon Viaud
Stoyan IvanovStoyan Ivanov
Stoyan Ivanov
NVNemanja Vujic
Nemanja Vujic
MDMadalina Duta-Mare
Madalina Duta-Mare
LALazaro-Emilio Aira
Lazaro-Emilio Aira
LYLaurent Yvan-Charvet
Laurent Yvan-Charvet
Rationale:: Macrophages face a substantial amount of cholesterol after the ingestion of apoptotic cells, and the LIPA (lysosomal acid lipase) has a major role in hydrolyzing cholesteryl esters in the endocytic compartment. Objective:: Here, we directly investigated the role of LIPA-mediated clearance of apoptotic cells both in vitro and in vivo. Methods and Results:: We show that LIPA inhibition causes a defective efferocytic response because of impaired generation of 25-hydroxycholesterol and 27-hydroxycholesterol. Reduced synthesis of 25-hydroxycholesterol after LIPA inhibition contributed to defective mitochondria-associated membrane leading to mitochondrial oxidative stress–induced NLRP3 (NOD-like receptor family, pyrin domain containing) inflammasome activation and caspase-1–dependent Rac1 (Ras-related C3 botulinum toxin substrate 1) degradation. A secondary event consisting of failure to appropriately activate liver X receptor–mediated pathways led to mitigation of cholesterol efflux and apoptotic cell clearance. In mice, LIPA inhibition caused defective clearance of apoptotic lymphocytes and stressed erythrocytes by hepatic and splenic macrophages, culminating in splenomegaly and splenic iron accumulation under hypercholesterolemia. Conclusions:: Our findings position lysosomal cholesterol hydrolysis as a critical process that prevents metabolic inflammation by enabling efficient macrophage apoptotic cell clearance.